Table 4.
Prognostic value of the primary symptoms in patients with diffuse glioma in group 2 by log-rank test.
| Primary symptom | 2A (G 2–3) |
2B (G 4) |
Whole Group (G 2–4) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Prognosis (p) | 95% CI for Mean Survival | Prognosis (p) | 95% CI for Mean Survival | Prognosis (p) | 95% CI for Mean Survival | ||||
| Lower | Upper | Lower | Upper | Lower | Upper | ||||
| Epileptic seizure | N.S. | 2253 | 4139 | N.S. | 521 | 1340 | + (0.002) | 1530 | 3039 |
| Motor dysfunction | – (<0.001) | 9 | 309 | N.S. | 84 | 814 | – (<0.001) | 96 | 616 |
| Cognitive disorder | N/A | – (0.006) | 143 | 380 | N.S. | 318 | 968 | ||
| Headache | N.S. | 745 | 4957 | + (0.020) | 687 | 2090 | N.S. | 1131 | 3339 |
| Sensory symptom | N.S. | 393 | 4105 | N/A | N.S. | 993 | 4062 | ||
| Visual or other sense-impairing symptom | N/A | N.S. | 0 | 1674 | N.S. | 0 | 1674 | ||
| Tumor hemorrhage | N/A | N/A | N/A | ||||||
| Speech disorder | N/A | N.S. | 131 | 1700 | N.S. | 445 | 1653 | ||
| Dizziness | N/A | N/A | N/A | ||||||
+Predicts a better prognosis compared with other patients. –Predicts a worse prognosis compared with other patients. G, tumor grade; N/A, not available; N.S., no significant prognostic value.